Annual report pursuant to Section 13 and 15(d)

Changes in Statements of Stockholders' Equity (Deficiency)

v3.3.1.900
Changes in Statements of Stockholders' Equity (Deficiency) - USD ($)
Total
Common Stock
APIC
Accumulated Deficit
Convertible Series B Preferred
Beginning Balance at Dec. 31, 2013 $ (29,600) $ 12,915 $ 2,594,128 $ (2,636,643)  
Beginning Balance, Shares at Dec. 31, 2013   12,915,343    
Stock based compensation 305,018 305,018
Deferred offering costs (86,129) (86,129)
Conversion of convertible notes into Series B Preferred Stock 210,000 209,790 $ 210
Conversion of convertible notes into Series B Preferred Stock, Shares       210,000
Issuance of Series B Preferred Stock 2,489,999 $ 2,484,809 $ 5,190
Issuance of Series B Preferred Stock, Shares       5,190,000
Net loss (1,819,684) $ (1,819,684)
Ending Balance at Dec. 31, 2014 1,069,604 $ 12,915 $ 5,507,616 $ (4,456,327) $ 5,400
Ending Balance, Shares at Dec. 31, 2014   12,915,343     5,400,000
Stock based compensation $ 396,850 $ 396,850
Conversion of Series B Preferred Stock to common stock $ 5,400 $ (5,400)
Conversion of Series B Preferred Stock to common stock, Shares   5,400,000     (5,400,000)
Proceeds from the initial public offering, net $ 10,253,484 $ 11,250 $ 10,242,234
Proceeds from the initial public offering, net, Shares   11,250,000    
Proceeds from the concurrent offering 2,700,000 $ 2,700 2,697,300
Proceeds from the concurrent offering, Shares   2,700,000    
Exercise of compensation options 55,548 $ 56 55,492
Exercise of compensation options, Shares   55,548    
Deferred offering costs - initial public offering (785,197) $ (785,197)
Net loss (3,878,210) $ (3,878,210)
Ending Balance at Dec. 31, 2015 $ 9,812,079 $ 32,321 $ 18,114,295 $ (8,334,537)  
Ending Balance, Shares at Dec. 31, 2015   32,320,891